Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study

Drorit Merkel, Kalman Filanovsky, Anat Gafter-Gvili, Liat Vidal, Ariel Aviv, Moshe E. Gatt, Itay Silbershatz, Yair Herishanu, Ariela Arad, Tamar Tadmor, Najib Dally, Anatoly Nemets, Ory Rouvio, Aharon Ronson, Katrin Herzog-Tzarfati, Luiza Akria, Andrei Braester, Ilana Hellmann, Shay Yeganeh, Arnon NaglerRonit Leiba, Moshe Mittelman, Yishai Ofran*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

58 Scopus citations

Fingerprint

Dive into the research topics of 'Predicting infections in high-risk patients with myelodysplastic syndrome/acute myeloid leukemia treated with azacitidine: Aretrospective multicenter study'. Together they form a unique fingerprint.

Keyphrases

Biochemistry, Genetics and Molecular Biology

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology